1. Scrip
  2. >>Therapy Areas

Vascepa Included In European Dyslipidemia Guidelines Ahead Of Approval

 
• By Mandy Jackson

Amarin won't seek approval in the EU until later this year, but doctors there are encouraged to consider Vascepa for patients with high triglycerides despite statin therapy. Also, PCSK9 inhibitor guidelines were solidified for very high risk patients.

Anatomy of Human Heart
New European guidelines recognize Vascepa's cardiovascular benefits. • Source: Shutterstock

Amarin Corp. PLC hasn't even sought European Medicines Agency (EMA) approval for its purified fish oil therapy Vascepa (icosapent ethyl) to treat hypertriglyceridemia, but already the drug has won an endorsement from the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) in new dyslipidemia treatment guidelines presented on 2 September at the ESC Congress in Paris.

The ESC/EAS guidelines now state that doctors should consider prescribing Vascepa for patients who have high triglyceride levels despite treatments...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiovascular

More from Therapy Areas

Celldex Bullish On Barzolvolimab Despite Study Miss

 
• By Kevin Grogan

All eyes on chronic urticaria after eosinophilic esophagitis disappointment.

BioNTech/BMS Bispecific Shows Early Promise In Small Cell Lung Cancer

 
• By Andrew McConaghie

An updated abstract from the World Conference on Lung Cancer has given analysts confidence in BioNTech’s VEGF-A/PD-L1 bispecific challenger

China-Originated Assets Lead Global GLP-1 Deals

 
• By Xu Hu

The total value of deals for GLP-1-associated assets so far this year is already double that of the previous two years combined, with China-originated molecules accounting for a substantial majority. Scrip takes a look at some of the key factors behind this activity.